Turmeric quality across climates: a review of agronomic variation, pharmacological activity and its emerging role in clinical emergency management
Year: 2026
Type: article
Abstract: Ethnopharmacological relevance Curcuma longa L. (turmeric) is an important medicinal and culinary plant and a major source of curcuminoids and volatile oils with diverse pharmacological activities. However, its phytochemical composition varies according to cultivar, genotype × environment interactions, climate, soil characteristics, cultivation practices, and post-harvest processing, creating challenges for reproducibility and standardization of turmeric-derived preparations. Aim of the study This review aimed to examine the influence of climatic, geographic, genetic, and agronomic factors on turmeric quality and phytochemical composition, and to critically evaluate the pharmacological evidence and proposed relevance of turmeric and curcumin in acute and emergency-care settings. Materials and methods A comprehensive narrative review was undertaken covering agronomic determinants, phytochemical variability, pharmacological mechanisms, bioavailability and formulation strategies, safety, herb–drug interactions, and evidence relevant to emergency medicine. Human studies were prioritized for clinical interpretation, whereas animal and in vitro studies were considered primarily for mechanistic and translational evidence. Results Evidence indicates substantial variation in curcuminoid and volatile-oil profiles across cultivars, geographic regions, production environments, and processing conditions. While tropical or high-altitude environments may enhance curcuminoid accumulation in several studies, no universal positive altitude–curcumin correlation holds across all agroecologies, as genotype × environment interactions and edaphic factors heavily modulate biosynthesis. Curcumin demonstrates anti-inflammatory, antioxidant, antimicrobial, immunomodulatory, and hepatoprotective activities involving interconnected pathways, particularly NF-κB-, Nrf2-, and cytokine-related signalling. However, evidence for emergency-medicine applications remains heterogeneous and is predominantly preclinical for conditions such as sepsis, acute lung injury, acute liver injury, and acute cardiovascular injury. Selected human studies provide supportive evidence in specific inflammatory, infectious, and wound-related contexts, but these findings cannot be directly extrapolated to time-critical emergency care. Poor systemic bioavailability, formulation-dependent pharmacokinetics, variability in phytochemical composition, dose and formulation heterogeneity, limited emergency-specific clinical trials, and regulatory and standardization challenges remain important barriers to translation. Conclusions Turmeric and curcumin possess promising pharmacological properties relevant to several acute pathological processes, but current evidence does not establish turmeric or curcumin as an evidence-based replacement for standard emergency treatments. Future research should integrate agronomic provenance, phytochemical standardization, precision agriculture, metabolomics-assisted breeding, chemometric authentication, digital traceability, artificial intelligence-assisted quality prediction, optimized delivery systems, and well-designed clinical studies to determine whether reproducible clinical benefits can be achieved.
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W7225119605